LMR Partners’s Vir Biotechnology VIR Stock Holding History

LMR Partners’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$691K	Hold	67,800	–	–	﹤0.01%	1125
2026 Q1	$607K	Hold	67,800	–	–	﹤0.01%	1065
2025 Q4	$409K	Sell	67,800 -100,000	-60%	-$595K	﹤0.01%	1147
2025 Q3	$958K	Hold	167,800	–	–	﹤0.01%	947
2025 Q2	$846K	Buy	167,800 +20,000	+14%	+$107K	0.01%	829
2025 Q1	$958K	Buy	+147,800	New	+$1.31M	0.01%	796
2021 Q3	–	Sell	-9,500	Closed	-$449K	–	1204
2021 Q2	$449K	Buy	9,500 +5,021	+112%	+$228K	0.01%	700
2021 Q1	$230K	Buy	+4,479	New	+$241K	0.01%	775

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LMR Partners's VIR Position: Q2 2026 in Review

LMR Partners held its Vir Biotechnology (VIR) position steady in Q2 2026 at 67,800 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

LMR Partners first reported a position in VIR in Q1 2021 and has held it in 8 quarters since. The position peaked at $958K in Q3 2025. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

LMR Partners held 67,800 shares of Vir Biotechnology worth $691K as of Q2 2026.
LMR Partners left its Vir Biotechnology share count unchanged in Q2 2026.
Vir Biotechnology made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1125 holding.
LMR Partners first reported a position in Vir Biotechnology in Q1 2021 and has held it in 8 quarters since.
LMR Partners's Vir Biotechnology position peaked at $958K in Q3 2025.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.